List of works - Vânia Vilas-Boas

Cocaine-induced kidney toxicity: an in vitro study using primary cultured human proximal tubular epithelial cells

scientific article published on 8 October 2011

Combining CXCR4-targeted and nontargeted nanoparticles for effective unassisted in vitro magnetic hyperthermia.

scientific article published on 5 February 2018

Development of novel rifampicin-derived P-glycoprotein activators/inducers. synthesis, in silico analysis and application in the RBE4 cell model, using paraquat as substrate

scientific article (publication date: 2013)

Green synthesis of fluorescent carbon dots from spices for in vitro imaging and tumour cell growth inhibition.

scientific article

Hepatotoxicity induced by nanomaterials: mechanisms and in vitro models

scientific article published on 06 November 2020

Industrial, Biocide, and Cosmetic Chemical Inducers of Cholestasis

scientific article published on 18 June 2019

Interaction of polyacrylic acid coated and non-coated iron oxide nanoparticles with human neutrophils.

scientific article published on 26 November 2013

Mechanisms and in vitro models of drug-induced cholestasis

scientific article published on 10 April 2019

Mechanisms of P-gp inhibition and effects on membrane fluidity of a new rifampicin derivative, 1,8-dibenzoyl-rifampicin.

scientific article published on 16 May 2013

Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy.

scientific article

P-glycoprotein activity in human Caucasian male lymphocytes does not follow its increased expression during aging

scientific article published on 8 September 2011

Performance enhanced UV/vis spectroscopic microfluidic sensor for ascorbic acid quantification in human blood

scientific article published on 18 May 2016

Primary hepatocytes and their cultures for the testing of drug-induced liver injury

scientific article published on 01 September 2018

RBE4 cells are highly resistant to paraquat-induced cytotoxicity: studies on uptake and efflux mechanisms.

scientific article published on 18 September 2013

Several transport systems contribute to the intestinal uptake of Paraquat, modulating its cytotoxic effects.

scientific article

The mixture of "ecstasy" and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations

scientific article

Therapeutic concentrations of mitoxantrone elicit energetic imbalance in H9c2 cells as an earlier event

scientific article published on December 2013

List of works by Vânia Vilas-Boas

Cocaine-induced kidney toxicity: an in vitro study using primary cultured human proximal tubular epithelial cells

Combining CXCR4-targeted and nontargeted nanoparticles for effective unassisted in vitro magnetic hyperthermia.

Development of novel rifampicin-derived P-glycoprotein activators/inducers. synthesis, in silico analysis and application in the RBE4 cell model, using paraquat as substrate

Green synthesis of fluorescent carbon dots from spices for in vitro imaging and tumour cell growth inhibition.

Hepatotoxicity induced by nanomaterials: mechanisms and in vitro models

Industrial, Biocide, and Cosmetic Chemical Inducers of Cholestasis

Interaction of polyacrylic acid coated and non-coated iron oxide nanoparticles with human neutrophils.

Mechanisms and in vitro models of drug-induced cholestasis

Mechanisms of P-gp inhibition and effects on membrane fluidity of a new rifampicin derivative, 1,8-dibenzoyl-rifampicin.

Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy.

P-glycoprotein activity in human Caucasian male lymphocytes does not follow its increased expression during aging

Performance enhanced UV/vis spectroscopic microfluidic sensor for ascorbic acid quantification in human blood

Primary hepatocytes and their cultures for the testing of drug-induced liver injury

RBE4 cells are highly resistant to paraquat-induced cytotoxicity: studies on uptake and efflux mechanisms.

Several transport systems contribute to the intestinal uptake of Paraquat, modulating its cytotoxic effects.

The mixture of "ecstasy" and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations

Therapeutic concentrations of mitoxantrone elicit energetic imbalance in H9c2 cells as an earlier event